Feature|Videos|August 4, 2026
From Vision to Commercialization: How Rentschler Biopharma Partners for Client Success
Key Takeaways
- Understand how 50 years of biologics manufacturing experience and a 150-year company legacy translate to de-risked development and regulatory confidence.
- Explore Rentschler's dual-site manufacturing model and how access to both U.S. and EU capabilities supports market-specific regulatory pathways and launch strategies.
Detra Glinatsis explains how a family-owned CDMO with 50 years of biologics experience is positioning clients for success in an era of tariffs and regulatory complexity.
Sponsored by Rentschler Biopharma
Rentschler Biopharma brings 150 years of company heritage and 50 years of dedicated biologics manufacturing to the contract development and manufacturing landscape. In this interview for BioPharm International, Detra Glinatis, Head of Business Development in the U.S., discusses Rentschler's proven track record of supporting over 40 BLA submissions and more than 150 IND and IMPD submissions across the full spectrum of development. With dual manufacturing facilities—one in the EU and a recent commercial-scale facility in Massachusetts—Rentschler serves as a reliable partner positioned to meet clients' regulatory and market-access needs.
The company's approach centers on understanding each client's unique drivers at every development phase. Early-stage programs benefit from Rentschler's awareness of downstream commercialization requirements, allowing the company to design development-stage processes with long-term viability in mind. This forward-looking strategy, combined with deep expertise in both early and late-stage manufacturing, enables clients to de-risk their programs and maintain momentum toward regulatory submission and launch. Glinatis emphasizes the importance of partnership flexibility—adapting to each client's working style and communication preferences while maintaining consistent quality and scientific rigor.
Biopharmaceutical companies seeking a CDMO partner that combines manufacturing heritage with strategic foresight will find value in understanding how Rentschler's integrated capabilities and adaptive partnership model accelerate the path from concept to commercial success.
